173 related articles for article (PubMed ID: 2162299)
1. Chemoprophylaxis of gram-negative infections in neutropenic patients.
Klastersky J
Eur Urol; 1990; 17 Suppl 1():40-5. PubMed ID: 2162299
[TBL] [Abstract][Full Text] [Related]
2. A review of chemoprophylaxis and therapy of bacterial infections in neutropenic patients.
Klastersky J
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):201S-207S. PubMed ID: 2686921
[TBL] [Abstract][Full Text] [Related]
3. Prevention of infections in the neutropenic patient.
Verhoef J
Clin Infect Dis; 1993 Nov; 17 Suppl 2():S359-67. PubMed ID: 8274601
[TBL] [Abstract][Full Text] [Related]
4. Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration.
Bow EJ; Rayner E; Scott BA; Louie TJ
Antimicrob Agents Chemother; 1987 Apr; 31(4):551-7. PubMed ID: 3300532
[TBL] [Abstract][Full Text] [Related]
5. Protecting neutropenic patients from bowel-derived organisms.
Warren RE
J Hosp Infect; 1991 Sep; 19 Suppl C():43-58. PubMed ID: 1684195
[TBL] [Abstract][Full Text] [Related]
6. Aztreonam in the prevention and treatment of infection in neutropenic cancer patients.
Rolston KV; Bodey GP; Elting L
Am J Med; 1990 Mar; 88(3C):24S-29S; discussion 38S-42S. PubMed ID: 2180294
[TBL] [Abstract][Full Text] [Related]
7. Emerging role of quinolones in the prevention of gram-negative bacteremia in neutropenic cancer patients and in the treatment of enteric infections.
Bow EJ; Louie TJ
Clin Invest Med; 1989 Feb; 12(1):61-8. PubMed ID: 2646056
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis of bacterial infections with oral antibiotics in neutropenic patients. Lessons from the last two EORTC trials and prospects for the future.
Zinner SH
Schweiz Med Wochenschr Suppl; 1983; 14():7-14. PubMed ID: 6361995
[TBL] [Abstract][Full Text] [Related]
9. The use of aminoglycosides in neutropenic patients.
Cometta A; Glauser MP
Schweiz Med Wochenschr Suppl; 1996; 76():21S-27S. PubMed ID: 8677415
[TBL] [Abstract][Full Text] [Related]
10. Combating infections in neutropenic patients.
Pizzo PA
Hosp Pract (Off Ed); 1989 Jul; 24(7):93-100, 103-4, 107-10. PubMed ID: 2501330
[TBL] [Abstract][Full Text] [Related]
11. Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients.
Henry SA
Am J Med; 1984 Apr; 76(4):645-51. PubMed ID: 6369979
[TBL] [Abstract][Full Text] [Related]
12. Reduction in mortality from gram-negative sepsis in neutropenic patients receiving trimethoprim/sulfamethoxazole therapy.
Riben PD; Louie TJ; Lank BA; Kornachuk E; Gurwith MJ; Harding GK; Ronald AR
Cancer; 1983 May; 51(9):1587-92. PubMed ID: 6339029
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial prophylaxis in the neutropenic host: lessons of the past and perspectives for the future.
Young LS
Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):93-7. PubMed ID: 3132393
[TBL] [Abstract][Full Text] [Related]
14. Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group.
J Infect Dis; 1984 Sep; 150(3):372-9. PubMed ID: 6384377
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.
Gafter-Gvili A; Fraser A; Paul M; van de Wetering M; Kremer L; Leibovici L
Cochrane Database Syst Rev; 2005 Oct; (4):CD004386. PubMed ID: 16235360
[TBL] [Abstract][Full Text] [Related]
16. Prevention of bacterial and fungal infections in granulocytopenic patients.
Verhoef J; Rozenberg-Arska M; Dekker AW
Eur J Cancer Clin Oncol; 1989 Sep; 25(9):1345-50. PubMed ID: 2680513
[TBL] [Abstract][Full Text] [Related]
17. Use of the quinolones for the prophylaxis and therapy of infections in immunocompromised hosts.
Maschmeyer G
Drugs; 1993; 45 Suppl 3():73-80. PubMed ID: 7689455
[TBL] [Abstract][Full Text] [Related]
18. Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora.
Kauffman CA; Liepman MK; Bergman AG; Mioduszewski J
Am J Med; 1983 Apr; 74(4):599-607. PubMed ID: 6837588
[No Abstract] [Full Text] [Related]
19. [Prevention of bacterial and fungal infections in neutropenic patients with malignant hematologic diseases].
Candoni A; Russo D; Salmaso F
Clin Ter; 1997; 148(1-2):23-8. PubMed ID: 9377834
[TBL] [Abstract][Full Text] [Related]
20. Prevention of infections in neutropenic patients with pefloxacin.
Meunier F
J Antimicrob Chemother; 1990 Oct; 26 Suppl B():69-73. PubMed ID: 2258354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
